Keystone Financial Group Reduces Stake in Teva Pharmaceutica

Keystone Financial Group trimmed its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 1.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 46,354 shares of the company’s stock after selling 900 shares during the quarter. Keystone […]

Related Keywords

Los Angeles , California , United States , Israel , Wellington , New Zealand General , New Zealand , America , Vikkil Conway , Amir Weiss , Piper Sandler , Goldman Sachs Group , Los Angeles Capital Management , Wellington Management Group , Quarter For Teva Pharmaceutical Industries , Sg Americas Securities , Gateway Investment Advisers , Teva Pharmaceutical Industries Profile , Barclays , Jpmorgan Chase Co , News Ratings For Teva Pharmaceutical Industries Daily , Teva Pharmaceutical Industries , Teva Pharmaceutical Industries Stock Down , Jefferies Financial Group , Teva Pharmaceutical Industries Limited , Keystone Financial Group , Free Report , Financial Group , Angeles Capital Management , Management Group , Investment Advisers , Pharmaceutical Industries Stock Down , Pharmaceutical Industries Limited , North America , Visit Holdingschannel , Teva Pharmaceutical Industries Daily ,